Members | Facebook | Twitter
Rhode Island Society of Health System Pharmacists
Lunch & Learn CE QUANTifying the Benefit of Quizartinib: Review of the QuANTUM-First Trial for FLT3-Mutated Acute Myeloid Leukemia
Pharmacists
1:00pm to 2:00pm
Look for Live Webinar Link in Confirmation Email!
Topics:
QUANTifying the Benefit of Quizartinib: Review of the QuANTUM-First Trial for FLT3-Mutated Acute Myeloid LeukemiaJenna Wu, the PGY-2 Oncology Resident at Rhode Island Hospital
Members: FREE
Non-Members: $10Please register on-line only. Please do not mail in registrations. Fees are payable at sign-in or online via Paypal Online:http://www.rishp.org. Refund requests must be made by written request and are at the discretion of the RISHP Board of Directors.
Learning Objectives
At the completion of this activity, pharmacists will be able to:
Describe the pathophysiology of acute myeloid leukemia (AML)
Discuss current literature and guideline recommendations for treatment of FLT3-positive AML
Evaluate the results from the QuANTUM-First trial and its implications in clinical practice
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based educational activity provides 1.0 live contact hour (0.1 ceus) to participants who meet the requirements for CE. No partial credit is available.
UNIVERSAL ACTIVITY NUMBER (UAN)Pharmacists: 0060-9999-23-068-L01-P PROGRAM EVALUATIONAll participants will have the opportunity to evaluate the educational session and speaker and to identify future educational needs.
REQUIREMENTS FOR CE CREDIT A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.
DISCLOSURE No person involved in the planning of this educational activity have any relevant financial relationships to disclose.
RISHP President
For website issues issues, please click here
